Facts of Olysio Simeprevir Capsules 150 mg ?

  • Medicine Name: OLYSIO
  • Generic Name: SIMEPREVIR
  • Date of Approval: 25.11.2013
  • Company Name: Johnson & Johnson's pharmaceutical division Janssen Pharmaceutica.

What is Olysio Simeprevir Capsules 150 mg ?

Olysio is Indicated for treatment of chronic hepatitis C (CHC); efficacy has been established in combination with peginterferon alfa and ribavirin in patients with HCV genotype 1 infection with compensated liver disease (including cirrhosis)

Quote From www.olysio.com

What are the indications and usage? ?

OLYSIO is a hepatitis C virus (HCV) NS3/4A protease inhibitor indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen.

  • OLYSIO efficacy has been established in combination with peginterferon alfa and ribavirin in HCV genotype 1 infected subjects with compensated liver disease (including cirrhosis).
  • OLYSIO must not be used as monotherapy. (
  • Screening patients with HCV genotype 1a infection for the presence of virus with the NS3 Q80K polymorphism at baseline is strongly recommended. Alternative therapy should be considered for patients infected with HCV genotype 1a containing the Q80K polymorphism.

Quote From www.olysio.com

What is the treatment duration?

  • In all patients, simeprevir should be initiated in combination with peginterferon alfa and ribavirin and should be administered for 12 weeks

  • All treatment-naïve and prior relapser patients, including those with cirrhosis, should receive an additional 12 weeks of peginterferon alfa and ribavirin after completing 12 weeks of treatment with simeprevir, peginterferon alfa and ribavirin (total treatment duration of 24 weeks)

  • All prior nonresponders (including partial and null-responders and those with cirrhosis), should receive an additional 36 weeks of peginterferon alfa and ribavirin after completing 12 weeks of simeprevir, peginterferon alfa and ribavirin (total treatment duration of 48 weeks)

Quote From www.olysio.com

Discontinue if inadequate virologic response:

  • Monitor HCV RNA levels to determine virologic response

  • It is unlikely that patients with inadequate on-treatment virologic response will achieve a sustained virologic response (SVR), therefore discontinuation of treatment is recommended in these patients

  • HCV-RNA levels at week 4 ≥25 IU/mL: Discontinue simeprevir, peginterferon alfa, and ribavirin

  • HCV-RNA levels at week 4 ≥25 IU/mL: Discontinue simeprevir, peginterferon alfa, and ribavirinHCV-RNA levels at week 12 ≥25 IU/mL: Discontinue peginterferon alfa and ribavirin (treatment with simeprevir completed at week 12), and ribavirin

  • HCV-RNA levels at week 24 ≥25 IU/mL: Discontinue peginterferon alfa and ribavirin

NAMED PATIENT SUPPLY

OLYSIO Simeprevir 150mg Capsules

OLYSIO Prescribing information

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915
E:info@ikrispharmanetwork.com

Query Form

What is the best price of Olysio Simeprevir Capsules 150 mg 400mg?

Please contact +91 8130290915 for price of OLYSIO in India

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Where can I Buy Olysio Simeprevir Capsules 150 mg 400mg?

IKRIS PHARMA NETWORK connects buyer with the supplier who can ship OLYSIO to any country of the world as per the buyer's requirement and Government regulations of the country. OLYSIO is manufactured by Johnson & Johnson's pharmaceutical division Janssen Pharmaceutica

IKRIS PHARMA NETWORK provides options of choosing exporter and supplier of Medicines related to treatment of Hepatitis c

Is OLYSIO available in India?

OLYSIO is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IKRIS Pharma Network facilitates import of cancer medicines on the named patient supply. IKRIS Pharma Network is facilitator providing input

  • On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
  • Medicine Price.
  • Finding Genuine and reliable source from Canada, Europe, USA and Australia
  • Ensuring 100% transparency.

OLYSIO can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India"

IKRIS Pharma Network can facilitate the supply of OLYSIO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

How order will be confirmed ?

The order will be confirmed only after the receipt of

  1. Valid prescription of Clinician
  2. Import permit if applicable

Send your enquiry to find the

Cost of Olysio Simeprevir Capsules 150 mg in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.

Disclaimer

General disclaimer under Facts and usage:
Please note that all information in relation to this drug is of general nature and may not be applicable to your specific situation and circumstance. Any information available here is not a substitute for professional medical advice by a licensed practitioner. We will help you in importing this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present.

General disclaimer under where can I buy the medicine/is the medicine available in India:
Please note that Ikris Pharma Network is a consultancy company, which facilitates patients, hospitals, clinicians and researchers in accessing products, which are not available or approved in their home country. Ikris Pharma Network has no relation whatsoever with this medicine including but not limited to being its manufacturer, seller, reseller, distributor, agent or licensee. Ikris Pharma will not purchase this medicine but will only assist you in doing so against a valid prescription and other documents as required by the laws of the jurisdiction in which you are present. None of the trademarks and other intellectual property and proprietary marks of this medicine belong to or are claimed to belong to the Ikris Pharma Network.